» Authors » Karsten-Henrich Weylandt

Karsten-Henrich Weylandt

Explore the profile of Karsten-Henrich Weylandt including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 11
Citations 256
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Kirchhoff R, Kampschulte N, Rothweiler C, Rohwer N, Weylandt K, Schebb N
Mol Nutr Food Res . 2024 Dec; 69(1):e202400716. PMID: 39676434
Evidence suggests beneficial effects of long-chain n-3 polyunsaturated fatty acids (PUFAs) in inflammatory diseases. However, the underlying mechanisms are still subject of research. For this purpose, we developed an ex...
2.
Albrecht H, Gustavus D, Schwanemann J, Dammermann W, Lippek F, Weylandt K, et al.
Cytotherapy . 2023 Feb; 25(5):537-547. PMID: 36775787
Adoptive cell therapy (ACT) using specific immune cells and stem cells has emerged as a promising treatment option that could complement traditional cancer therapies in the future. In particular, tumor-infiltrating...
3.
Enssle J, Weylandt K
Biotechniques . 2021 May; 70(6):345-349. PMID: 33956487
The  reference single-nucleotide polymorphism rs738409 has been identified as a predisposing factor for nonalcoholic fatty liver disease. A simple method based on PCR and restriction fragment length polymorphism (RFLP) analysis...
4.
Rohwer N, Chiu C, Huang D, Smyl C, Rothe M, Rund K, et al.
FASEB J . 2021 Mar; 35(4):e21491. PMID: 33710695
An increased omega-3 polyunsaturated fatty acid (n-3 PUFA) tissue status can lead to a significant formation of anti-inflammatory lipid mediators and effective reduction in inflammation and tissue injury in murine...
5.
Spachmann P, May M, Vetterlein M, Fritsche H, Steffen S, Schostak M, et al.
Caspian J Intern Med . 2019 Aug; 10(2):132-141. PMID: 31363391
Background: Recently, antibiotic resistance rates have risen substantially and care for patients infected with multidrug-resistant organisms (MDRO) has become a common problem in most in - and outpatient settings. The...
6.
Pevny S, Maasberg S, Rieger A, Karber M, Bluthner E, Knappe-Drzikova B, et al.
Clin Nutr . 2018 Aug; 38(4):1745-1755. PMID: 30145039
Background & Aims: Teduglutide, a glucagon-like peptide 2 (GLP-2) analog, is an approved medication specific for short bowel syndrome patients with chronic intestinal failure (SBS-IF). Due to its intestinotrophic properties,...
7.
Kroschwald S, Chiu C, Heydeck D, Rohwer N, Gehring T, Seifert U, et al.
Biochim Biophys Acta Mol Cell Biol Lipids . 2018 Apr; 1863(8):866-880. PMID: 29702245
Lipoxygenases (ALOXs) are involved in the regulation of cellular redox homeostasis. They also have been implicated in the biosynthesis of pro- and anti-inflammatory lipid mediators and play a role in...
8.
Schunck W, Konkel A, Fischer R, Weylandt K
Pharmacol Ther . 2017 Oct; 183:177-204. PMID: 29080699
Numerous benefits have been attributed to dietary long-chain omega-3 polyunsaturated fatty acids (n-3 LC-PUFAs), including protection against cardiac arrhythmia, triglyceride-lowering, amelioration of inflammatory, and neurodegenerative disorders. This review covers recent...
9.
Swidsinski A, Dorffel Y, Loening-Baucke V, Gille C, Goktas O, Reisshauer A, et al.
Front Microbiol . 2017 Jul; 8:1141. PMID: 28702003
Colonic microbiome is thought to be involved in auto-immune multiple sclerosis (MS). Interactions between diet and the colonic microbiome in MS are unknown. We compared the composition of the colonic...
10.
Ostermann A, Reutzel M, Hartung N, Franke N, Kutzner L, Schoenfeld K, et al.
Prostaglandins Other Lipid Mediat . 2017 Jun; 133:79-87. PMID: 28583889
Several studies suggest that intake of omega-3 polyunsaturated fatty acids (n3-PUFA) beneficially influences cognitive function. However, effects on the adult brain are not clear. Little is known about the impact...